Health
National clinical trial launches, will test promising vaccine against novel coronavirus – EurekAlert
UC San Diego Health and the Altman Clinical and Translational Research Institute will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the coronavirus that cause…
IMAGE: Colorized scanning electron micrograph of SARS-CoV-2 coronavirus (gold spheres).
view more
Credit: NIAID-RML
UC San Diego Health and the Altman Clinical and Translational Research Institute, part of UC San Diego School of Medicine, will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the novel coronavirus that causes COVID-19.
The trial, sponsored by the National Institutes of Health’…
